GlassScriptPhysician profile
Jonathan Garino
NPI 1952339731
$3,790,602.96
in general payments reported to CMS, 2019-2025
25 companies · $573K in 2025
The $573K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620K · 2020: $461K · 2021: $481K · 2022: $544K · 2023: $546K · 2024: $566K · 2025: $573K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.7M · Food and Beverage: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,684,564.16 |
| Food and Beverage | $923.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,788,720.23 | 2019-2025 | Journey II, Journey II Xr, Journey |
| Stryker Corporation | $420.68 | 2019-2024 | Optablate, Omnicurve, Insignia |
| Zimmer Biomet Holdings, INC. | $310.83 | 2019-2023 | Gel-One Cross-Linked Hyaluronate |
| Heraeus Medical, LLC. | $226.10 | 2020-2025 | Palacos |
| Davol INC. | $184.09 | 2023 | |
| Uoc USA INC | $138.07 | 2021 | |
| Abbvie INC. | $66.77 | 2019-2023 | |
| Pacira Therapeutics, INC. | $64.83 | 2019-2021 | |
| Abbott Laboratories | $59.77 | 2024-2025 | Octrode |
| Depuy Synthes Sales INC. | $56.81 | 2019-2025 | Monovisc |
| Innovation Technologies INC | $54.41 | 2023 | Irrisept |
| Convatec INC. | $39.68 | 2023 | |
| Mallinckrodt Enterprises LLC | $31.08 | 2019 | |
| Heron Therapeutics, INC. | $30.65 | 2022-2024 | Zynrelef |
| Carbofix Orthopedics INC | $28.76 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $26.96 | 2022 | |
| Avanos Medical | $21.96 | 2022 | |
| Orthofix Medical, INC. | $20.27 | 2024 | Physio-Stim |
| Sanofi-Aventis U.S. LLC | $19.41 | 2022 | |
| Amgen INC. | $18.33 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.05 | 2025 | |
| Dynasplint Systems INC. | $16.01 | 2025 | Dynasplint |
| Orthogenrx INC. | $11.99 | 2020 | |
| Misonix INC | $11.56 | 2019 | |
| Lifenet Health | $5.66 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Garino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.